Aleve PM 25 mg/1 (DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM TABLET, FILM COATED) 25 mg/1

Aleve PM 25 mg/1 combines diphenhydramine and naproxen for relief. This dual-action tablet offers pain relief and sleep support. Ideal for those seeking comfort and rest.

Strength

25 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0280-1200-20) / 20 TABLET, FILM COATED in 1 BOTTLE

Manufacturer / TM Owner

Bayer HealthCare LLC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aleve PM 25 mg/1 is commonly used for pain relief and to aid sleep. The combination of diphenhydramine and naproxen targets minor aches and promotes relaxation. People often use this medication for what is Aleve PM used for, such as managing discomfort and improving sleep quality.

Side Effects

Users of Aleve PM 25 mg/1 may experience relief from pain and improved sleep. The diphenhydramine component can cause drowsiness, while naproxen works to reduce inflammation and discomfort. These effects vary depending on individual responses.

Precautions & Warnings

Handle Aleve PM 25 mg/1 with care, especially if you have allergies or medical conditions. Consult a healthcare provider before use, particularly if you are pregnant, breastfeeding, or taking other medications. Follow the instructions on the label for safe usage.

Avoid Interactions

Aleve PM 25 mg/1 may interact with alcohol, other pain relievers, and certain antidepressants. It's important to be cautious with CYP inhibitors and other medications that affect liver enzymes. Always check with a healthcare professional before combining with other treatments.

Frequently Asked Questions

Aleve PM 25 mg/1 is used for pain relief and to aid sleep. It combines diphenhydramine for relaxation and naproxen for reducing inflammation.

Aleve PM 25 mg/1 is taken orally, typically before bedtime. Follow the dosage instructions on the label or as directed by a healthcare provider.

Aleve PM 25 mg/1 may interact with other medications. Consult a healthcare provider before combining it with other treatments.

Common side effects may include drowsiness, dizziness, and mild stomach upset. Individual responses can vary.

Aleve PM 25 mg/1 is generally intended for short-term use. Prolonged use should be discussed with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.